يعرض 13,301 - 13,320 نتائج من 21,342 نتيجة بحث عن '(( significant decrease decrease ) OR ( significantly ((mean decrease) OR (greater decrease)) ))', وقت الاستعلام: 0.54s تنقيح النتائج
  1. 13301

    Image 5_The Effect of glycocholic acid on the growth, membrane permeability, conjugation and antibiotic susceptibility of Enterobacteriaceae.pdf حسب Bar Piscon (20906495)

    منشور في 2025
    "…These phenotypes are associated with repression of flagellin (fliC) transcription and a sharp decrease in the occurrence of conjugative pili in the presence of glycocholic acid, respectively.…"
  2. 13302

    Image 3_Spatial deciphering of the transcriptomic heterogeneity of tumor spread through air spaces in lung cancer.tif حسب Wenhao Wang (515852)

    منشور في 2025
    "…Meanwhile, an increase in CD4 T memory cells and a decrease in B cells were observed in the tumor immune microenvironment of STAS. …"
  3. 13303

    Table 1_Rainfall distribution variability controls surface but not belowground litter decomposition in a semi-arid shrubland.docx حسب Yulin Li (36434)

    منشور في 2025
    "…</p>Results<p>Decomposition of belowground litter was consistently higher than that of surface litter over the entire field-incubation process. Mass loss significantly decreased in surface litter but not in belowground litter due to the lower frequency and larger amount of precipitation compared to the control treatment. …"
  4. 13304

    The impact of anesthesia and positioning on cerebral blood flow and pressure in patients undergoing laparoscopic surgery: an randomised observational study حسب alon lord (20342469)

    منشور في 2024
    "…In the REV group, CCA flow decreased after the Reverse Trendelenburg position (P=0.0213). …"
  5. 13305

    The effect of EDF derived from <i>E</i>. <i>coli</i> (in mid-logarithmic growth phase, OD = 0.6) on the MRSA and MSSA. حسب Shahriar Bakhti (20391188)

    منشور في 2024
    "…In all the analyses, p<0.05 was considered statistically significant. The data were expressed as the mean value plus–minus the standard error of the mean (mean ± SEM).…"
  6. 13306

    Table 1_Prevalence and duration of clinical symptoms of pediatric long COVID: findings from a one-year prospective study.docx حسب Vita Perestiuk (22290208)

    منشور في 2025
    "…Younger age was associated with insomnia (OR = 0.49, p = 0.018). Female sex was significantly associated with a greater likelihood of lack of energy (OR = 2.55, p = 0.048). …"
  7. 13307

    Data Sheet 1_Prevalence and duration of clinical symptoms of pediatric long COVID: findings from a one-year prospective study.docx حسب Vita Perestiuk (22290208)

    منشور في 2025
    "…Younger age was associated with insomnia (OR = 0.49, p = 0.018). Female sex was significantly associated with a greater likelihood of lack of energy (OR = 2.55, p = 0.048). …"
  8. 13308

    Table 3_Prevalence and duration of clinical symptoms of pediatric long COVID: findings from a one-year prospective study.docx حسب Vita Perestiuk (22290208)

    منشور في 2025
    "…Younger age was associated with insomnia (OR = 0.49, p = 0.018). Female sex was significantly associated with a greater likelihood of lack of energy (OR = 2.55, p = 0.048). …"
  9. 13309

    Data Sheet 2_Prevalence and duration of clinical symptoms of pediatric long COVID: findings from a one-year prospective study.docx حسب Vita Perestiuk (22290208)

    منشور في 2025
    "…Younger age was associated with insomnia (OR = 0.49, p = 0.018). Female sex was significantly associated with a greater likelihood of lack of energy (OR = 2.55, p = 0.048). …"
  10. 13310

    Data Sheet 3_Prevalence and duration of clinical symptoms of pediatric long COVID: findings from a one-year prospective study.pdf حسب Vita Perestiuk (22290208)

    منشور في 2025
    "…Younger age was associated with insomnia (OR = 0.49, p = 0.018). Female sex was significantly associated with a greater likelihood of lack of energy (OR = 2.55, p = 0.048). …"
  11. 13311

    Table 2_Prevalence and duration of clinical symptoms of pediatric long COVID: findings from a one-year prospective study.docx حسب Vita Perestiuk (22290208)

    منشور في 2025
    "…Younger age was associated with insomnia (OR = 0.49, p = 0.018). Female sex was significantly associated with a greater likelihood of lack of energy (OR = 2.55, p = 0.048). …"
  12. 13312

    Data Sheet 4_Prevalence and duration of clinical symptoms of pediatric long COVID: findings from a one-year prospective study.docx حسب Vita Perestiuk (22290208)

    منشور في 2025
    "…Younger age was associated with insomnia (OR = 0.49, p = 0.018). Female sex was significantly associated with a greater likelihood of lack of energy (OR = 2.55, p = 0.048). …"
  13. 13313

    Supplementary Material for: The value of diffusion kurtosis imaging to assess liver and kidney recovery after mesenchymal stem cell intervention in CCl4-induced cirrhotic rats حسب Qin J. (5120975)

    منشور في 2025
    "…At week 16, the mean diffusion (MD) in the BMSC group was significantly higher than that at week 12 and in the control group. …"
  14. 13314

    Presentation 1_A phase 2a double-blind, placebo-controlled, randomized clinical trial evaluating the efficacy and safety of NuGel, a novel topical GPCR19-mediated inflammasome inhi... حسب Gyeong Ho Baek (21382907)

    منشور في 2025
    "…</p>Results<p>NuGel (0.3% [Nu0.3] and 0.5% [Nu0.5]) was well-tolerated, with no adverse drug reactions or serious adverse events. Nu0.3 showed a significant decrease in EASI score from baseline (-12.2%, [-30.3%, 5.9%], p = 0.04). …"
  15. 13315

    Presentation 3_A phase 2a double-blind, placebo-controlled, randomized clinical trial evaluating the efficacy and safety of NuGel, a novel topical GPCR19-mediated inflammasome inhi... حسب Gyeong Ho Baek (21382907)

    منشور في 2025
    "…</p>Results<p>NuGel (0.3% [Nu0.3] and 0.5% [Nu0.5]) was well-tolerated, with no adverse drug reactions or serious adverse events. Nu0.3 showed a significant decrease in EASI score from baseline (-12.2%, [-30.3%, 5.9%], p = 0.04). …"
  16. 13316

    Data Sheet 1_A phase 2a double-blind, placebo-controlled, randomized clinical trial evaluating the efficacy and safety of NuGel, a novel topical GPCR19-mediated inflammasome inhibi... حسب Gyeong Ho Baek (21382907)

    منشور في 2025
    "…</p>Results<p>NuGel (0.3% [Nu0.3] and 0.5% [Nu0.5]) was well-tolerated, with no adverse drug reactions or serious adverse events. Nu0.3 showed a significant decrease in EASI score from baseline (-12.2%, [-30.3%, 5.9%], p = 0.04). …"
  17. 13317

    Comparison of the trend of people’s perceptions and the climatic trends (social data: Quantitative data: Household survey (n = 660); qualitative data: Focus group discussions (n =... حسب Parbati Phuyal (8687400)

    منشور في 2025
    "…Depending on the perception, the presence of a trend (yes, no, unclear/mixed) or a trend direction (increase, decrease, unclear) is given. Significance of each data type is presented in detail in Figs <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0317786#pone.0317786.g002" target="_blank">2</a>–<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0317786#pone.0317786.g005" target="_blank">5</a>. …"
  18. 13318

    Data Sheet 2_A phase 2a double-blind, placebo-controlled, randomized clinical trial evaluating the efficacy and safety of NuGel, a novel topical GPCR19-mediated inflammasome inhibi... حسب Gyeong Ho Baek (21382907)

    منشور في 2025
    "…</p>Results<p>NuGel (0.3% [Nu0.3] and 0.5% [Nu0.5]) was well-tolerated, with no adverse drug reactions or serious adverse events. Nu0.3 showed a significant decrease in EASI score from baseline (-12.2%, [-30.3%, 5.9%], p = 0.04). …"
  19. 13319

    Presentation 2_A phase 2a double-blind, placebo-controlled, randomized clinical trial evaluating the efficacy and safety of NuGel, a novel topical GPCR19-mediated inflammasome inhi... حسب Gyeong Ho Baek (21382907)

    منشور في 2025
    "…</p>Results<p>NuGel (0.3% [Nu0.3] and 0.5% [Nu0.5]) was well-tolerated, with no adverse drug reactions or serious adverse events. Nu0.3 showed a significant decrease in EASI score from baseline (-12.2%, [-30.3%, 5.9%], p = 0.04). …"
  20. 13320

    Supplementary file 2_Practical utility of meropenem therapeutic drug monitoring: a systematic review of evidence for clinical application.docx حسب Yi-Chang Zhao (14080107)

    منشور في 2025
    "…CRP levels decreased significantly (mean difference = 14.91; 95% CI: 2.79–27.02), while changes in PCT, WBC, and neutrophil ratios were non-significant. …"